Abstract
Introduction
Although common in individuals with cancer as well as nerve root compression, neuropathic pain can be difficult to prevent and manage due to the complex pain mechanisms involved in its pathophysiology. Although contrast baths have a long history of use for pain management, there is little known about their efficacy in the acute rehabilitation setting or in patients with cancer related neuropathic pain.
Case presentation
A 54-year-old man with multiple myeloma presented with progressive lower extremity weakness and 8/10 neuropathic pain intensity in both feet due to extensive myelomatous involvement of his lumbar spine. The patient’s pain limited his participation in physical therapy despite an extensive pain medication regimen. At the discretion of the patient’s physical therapist, contrast bath therapy for this patient was initiated with a reduction in pain intensity to 3/10. This analgesic effect lasted for a period of up to 10 h, which allowed the patient to participate in 3 h of therapy daily and to sleep comfortably.
Discussion
Contrast baths are a simple and cost-effective therapy that can be performed independently. As demonstrated in this case, they can potentially provide marked improvement in neuropathic pain and, in the acute rehabilitation setting, may enable patients to better participate in intensive physical therapy.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Oosterling A, te Boveldt N, Verhagen C, van der Graaf WT, Van Ham M, Van der Drift M, et al. Neuropathic pain components in patients with cancer: prevalence, treatment, and interference with daily activities. Pain Pr. 2016;16:413–21. https://doi.org/10.1111/papr.12291.
Freynhagen R, Baron R, Tölle T, Stemmler E, Gockel U, Stevens M, et al. Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: A prospective observational pilot study (MIPORT). Curr Med Res Opin. 2006;22:529–37.
Petrofsky J, Lohman E 3rd, Lee S, de la Cuesta Z, Labial L, Iouciulescu R, et al. Effects of contrast baths on skin blood flow on the dorsal and plantar foot in people with type 2 diabetes and age-matched controls. Physiother Theory Pr. 2007;23:18997.
Breger Stanton DE, Lazaro R, Macdermid JC. A systematic review of the effectiveness of contrast baths. J Hand Ther. 2009;22:57–69.
Shadgan B, Pakravan AH, Hoens A, Reid WD. Contrast baths, intramuscular hemodynamics, and oxygenation as monitored by near-infrared spectroscopy. J Athl Train. 2018;53:782–7.
Soylev GO, Boya H. A rare complication of total knee arthroplasty: Type 1 complex regional pain syndrome of the foot and ankle. Acta Orthopaedica et Traumatologica Turc. 2016;50:592–5.
World Health Organization. https://www.who.int/cancer/palliative/painladder/en/.
Esin E, Yalcin S. Neuropathic cancer pain: What we are dealing with? How to manage it? Onco Targets Ther. 2014;7:599–618. https://doi.org/10.2147/OTT.S60995.
Caraceni A, Zecca E, Bonezzi C, Arcuri E, Yaya Tur R, Maltoni M, et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol. 2004;22:2909.
Jongen JL, Huijsman ML, Jessurun J, Ogenio K, Schipper D, Verkouteren DR, et al. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects. J Pain Symptom Manag. 2013;46:581.
Hepner S, Claxton R. Anti-epileptic drugs for pain #271. J Palliat Med. 2013;16:799.
Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237.
Garzón-Rodríguez C, Casals Merchan M, Calsina-Berna A, López-Rómboli E, Porta-Sales J. Lidocaine 5% patches as an effective short-term co-analgesic in cancer pain. Preliminary results. Support Care Cancer. 2013;21:3153.
Challapalli V, Tremont-Lukats IW, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev. 2005;2015:CD003345.
Ben-Ari A, Lewis MC, Davidson E. Chronic administration of ketamine for analgesia. J Pain Palliat Care Pharmacother. 2007;21:7.
Yomiya K, Matsuo N, Tomiyasu S, Yoshimoto T, Tamaki T, Suzuki T, et al. Baclofen as an adjuvant analgesic for cancer pain. Am J Hosp Palliat Care. 2009;26:112.
Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat Med. 2011;25:553.
Rhiner M, Ferrell BR, Ferrell BA, Grant MM. A structured nondrug intervention program for cancer pain. Cancer Pr. 1993;1:137.
Hurlow A, Bennett MI, Robb KA, Johnson MI, Simpson KH, Oxberry SG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev. 2012;2012:CD006276.
Park HS, Sin WK, Kim HY, Moon JY, Park SY, Kim YC, et al. Scrambler therapy for patients with cancer pain - case series. Korean J Pain. 2013;26:65.
National Center for Complementary and Integrative Health (https://nccih.nih.gov/).
Author information
Authors and Affiliations
Contributions
All authors participated in conception, evaluation, and writing of this case report.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Hatch, E.H., Gorrell, C. & Abramoff, B.A. Contrast bath therapy for neuropathic pain due to spinal nerve root compression by myeloma: a case report. Spinal Cord Ser Cases 8, 59 (2022). https://doi.org/10.1038/s41394-022-00526-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41394-022-00526-6
This article is cited by
-
Duloxetine/fentanyl/methadone
Reactions Weekly (2022)
